Ilseung Choi

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

Junichi Kiyasu, Hiroaki Miyoshi, Akie Hirata et al. · Blood · 2015 · 478 citations

Medicine, Cancer Biology, Oncology +12

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report

Lucy Cook, Shigeo Fuji, Olivier Hermine et al. · Journal of Clinical Oncology · 2019 · 257 citations · Full text

Medicine, Molecular Medicine, Oncology +14

Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality

Shigeo Fuji, Yoshitaka Inoue, Atae Utsunomiya et al. · Journal of Clinical Oncology · 2016 · 196 citations

Life Sciences, Hematology, Immunology +14

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13